Differential diagnosis of reactive gastropathy

Seminars in Diagnostic Pathology

Volumn 22, Issue 4, 2005, Pages 273-283

  Genta, Robert M ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Bile reflux; Chemical gastropathy; Drug induced damage; Erosions; Foveolar hyperplasia; Gastritis; Gastropathy; Nonsteroidal antiinflammatory agents; Reactive gastropathy

Indexed keywords

ACID; ALCOHOL; ALKALI; BISPHOSPHONIC ACID DERIVATIVE; CHLOROQUINE; COLCHICINE; CORTICOSTEROID; FERROUS SULFATE; NONSTEROID ANTIINFLAMMATORY AGENT; POLYSTYRENESULFONATE SODIUM; POTASSIUM;

ARTICLE; ATROPHY; CELL HYPERPLASIA; CHEMICAL INJURY; DIARRHEA; DIFFERENTIAL DIAGNOSIS; EDEMA; GASTRIC ULCER BLEEDING; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL PAIN; HISTOPATHOLOGY; HUMAN; HYPEREMIA; HYPERPLASIA; INFLAMMATION; INTESTINE METAPLASIA; LAMINA PROPRIA; LYMPHOCYTE; NAUSEA; NEUTROPHIL CHEMOTAXIS; OCCULT BLOOD; PANCREATITIS; PLASMA CELL; PRIORITY JOURNAL; RISK ASSESSMENT; SMOOTH MUSCLE FIBER; STOMACH BIOPSY; STOMACH DISEASE; STOMACH EROSION; STOMACH PARIETAL CELL; VOMITING;

ALGORITHMS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; GASTRIC MUCOSA; HUMANS; STOMACH DISEASES;

EID: 33746335029     PISSN: 07402570     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semdp.2006.04.001     Document Type: Article

References (68)

1. Beaumont W. Experiments and Observations on the Gastric Juice and the Physiology of Digestion (1959), Dover Publications, Inc, New York, NY
2. Krentz K. Gastroscopic and aspiration biopsy findings on the operated stomach. Dtsch Med Wochenschr 89 (1964) 664-671
3. Cotton P.B., Rosenberg M.T., Axon A.T., et al. Diagnostic yield of fibre-optic endoscopy in the operated stomach. Br J Surg 60 (1973) 629-632
4. Mosimann R., and Loup P. Postoperative gastritis caused by reflux. Apropos of 16 cases. Helv Chir Acta 45 (1978) 181-196
5. Lechner H.J., and Anton D. The histology of gastric mucosa in B II-stomach. Z Gastroenterol 17 (1979) 674-679
6. Offerhaus G.J., Huibregtse K., de Boer J., et al. The operated stomach: a premalignant condition? A prospective endoscopic follow-up study. Scand J Gastroenterol 19 (1984) 521-524
7. Langhans P., Bues M., and Bunte H. Morphological changes in the operated stomach under the influence of duodenogastric reflux. Clinical follow-up over 20 years. Scand J Gastroenterol Suppl 92 (1984) 145-148
8. Dewar E.P., Dixon M.F., and Johnston D. Bile reflux and degree of gastritis after highly selective vagotomy, truncal vagotomy, and partial gastrectomy for duodenal ulcer. World J Surg 7 (1983) 743-750
9. Dewar P., Dixon M.F., and Johnston D. Bile reflux and degree of gastritis in patients with gastric ulcer. before and after operation. J Surg Res 37 (1984) 277-284
10. Dixon M.F. Reflux gastritis. Acta Gastroenterol Belg 52 (1989) 292-296
11. Dixon M.F., O'Connor H.J., Axon A.T., et al. Reflux gastritis. distinct histopathological entity?. J Clin Pathol 39 (1986) 524-530
12. Sobala G.M., O'Connor H.J., Dewar E.P., et al. Bile reflux and intestinal metaplasia in gastric mucosa. J Clin Pathol 46 (1993) 235-240
13. Dixon M.F., Genta R.M., Yardley J.H., et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 20 (1996) 1161-1181
14. Laine L., and Weinstein W.M. Histology of alcoholic hemorrhagic "gastritis". a prospective evaluation. Gastroenterology 94 (1988) 1254-1262
15. Franzin G., Musola R., Zamboni G., et al. Gastritis cystica polyposa. a possible precancerous lesion. Tumori 71 (1985) 13-18
16. Koga S., Watanabe H., and Enjoji M. Stomal polypoid hypertrophic gastritis. a polypoid gastric lesion at gastroenterostomy site. Cancer 43 (1979) 647-657
17. Bekavac-Beslin M., and Halkic N. Gastric stump cancer after stomach resection due to peptic disease. Chir Ital 48 (1996) 9-12
18. Domellof L., Eriksson S., and Janunger K.G. Carcinoma and possible precancerous changes of the gastric stump after billroth II resection. Gastroenterology 73 (1977) 462-468
19. Geboes K., Rutgeerts P., Broeckaert L., et al. Histologic appearances of endoscopic gastric mucosal biopsies 10-20 years after partial gastrectomy. Ann Surg 192 (1980) 179-182
20. Greene F.L. Discovery of early gastric remnant carcinoma. Results of a 14-year endoscopic screening program. Surg Endosc 9 (1995) 1199-1203
21. Greene F.L. Management of gastric remnant carcinoma based on the results of a 15-year endoscopic screening program. Ann Surg 223 (1996) 701-706
22. Karttunen T., Niemela S., Lehtola J., et al. Campylobacter-like organisms and gastritis. histopathology, bile reflux, and gastric fluid composition. Scand J Gastroenterol 22 (1987) 478-486
23. Buxbaum K.L. Bile gastritis occurring after cholecystectomy. Am J Gastroenterol 77 (1982) 305-311
24. Rees W., and Rhodes J. Bile reflux in gastro-oesophageal disease. Clin Gastroenterol 6 (1977) 179-200
25. Chen S.L., Mo J.Z., Cao Z.J., et al. Effects of bile reflux on gastric mucosal lesions in patients with dyspepsia or chronic gastritis. World J Gastroenterol 11 (2005) 2834-2837
26. Abe H., Murakami K., Satoh S., et al. Influence of bile reflux and Helicobacter pylori infection on gastritis in the remnant gastric mucosa after distal gastrectomy. J Gastroenterol 40 (2005) 563-569
27. Fukuhara K., Osugi H., Takada N., et al. Duodenogastric reflux eradicates Helicobacter pylori after distal gastrectomy. Hepatogastroenterology 51 (2004) 1548-1550
28. Karat D., and Griffin S.M. Helicobacter pylori and surgery. Bile reflux is important in eradicating Helicobacter pylori. Br Med J 317 (1998) 679
29. El Zimaity H.M., Genta R.M., and Graham D.Y. Histological features do not define NSAID-induced gastritis. Hum Pathol 27 (1996) 1348-1354
30. Graham D.Y., and Smith J.L. Gastroduodenal complications of chronic NSAID therapy. Am J Gastroenterol 83 (1988) 1081-1084
31. Schoenfeld P., Kimmey M.B., Scheiman J., et al. Review article: nonsteroidal anti-inflammatory drug-associated gastrointestinal complications: guidelines for prevention and treatment. Aliment Pharmacol Ther 13 (1999) 1273-1285
32. Bijlsma J.W., Boers M., Saag K.G., et al. Glucocorticoids in the treatment of early and late RA. Ann Rheum Dis 62 (2003) 1033-1037
33. Graham D.Y., Smith J.L., Jones R.D., et al. Gastroscopic localization of a microencapsulated KCl preparation in the human stomach. Gastrointest Endosc 33 (1987) 220-223
34. Iacobuzio-Donahue C.A., Lee E.L., Abraham S.C., et al. Colchicine toxicity. distinct morphologic findings in gastrointestinal biopsies. Am J Surg Pathol 25 (2001) 1067-1073
35. Lowe C.E., Depew W.T., Vanner S.J., et al. Upper gastrointestinal toxicity of alendronate. Am J Gastroenterol 95 (2000) 634-640
36. Lanza F., Sahba B., Schwartz H., et al. The upper GI safety and tolerability of oral alendronate at a dose of 70 milligrams once weekly. a placebo-controlled endoscopy study. Am J Gastroenterol 97 (2002) 58-64
37. Abraham S.C., Yardley J.H., and Wu T.T. Erosive injury to the upper gastrointestinal tract in patients receiving iron medication. an underrecognized entity. Am J Surg Pathol 23 (1999) 1241-1247
38. Bhasin D.K., Chhina R.S., and Sachdeva J.R. Endoscopic assessment of chloroquine phosphate-induced damage to esophageal, gastric, and duodenal mucosa. Am J Gastroenterol 86 (1991) 434-437
39. Abraham S.C., Bhagavan B.S., Lee L.A., et al. Upper gastrointestinal tract injury in patients receiving kayexalate (sodium polystyrene sulfonate) in sorbitol. clinical, endoscopic, and histopathologic findings. Am J Surg Pathol 25 (2001) 637-644
40. Hawkey C.J. Nonsteroidal anti-inflammatory drug gastropathy. Gastroenterology 119 (2000) 521-535
41. Dixon M.F. The components of gastritis. histology and pathogenesis. In: Graham D.Y., Genta R.M., and Dixon M.F. (Eds). Gastritis (1999), Lippincott Williams & Wilkins, Philadelphia, PA
42. Sung J., Russell R.I., Nyeomans, et al. Non-steroidal anti-inflammatory drug toxicity in the upper gastrointestinal tract. J Gastroenterol Hepatol 15 suppl (2000) G58-G68
43. Graham D.Y., Agrawal N.M., Campbell D.R., et al. Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs. results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole. Arch Intern Med 162 (2002) 169-175
44. Dent J. Why proton pump inhibition should heal and protect against nonsteroidal anti-inflammatory drug ulcers. Am J Med 104 (1998) 52S-55S
45. Everts B., Wahrborg P., and Hedner T. COX-2-Specific inhibitors-the emergence of a new class of analgesic and anti-inflammatory drugs. Clin Rheumatol 19 (2000) 331-343
46. Waxman H.A. The lessons of Vioxx. drug safety and sales. N Engl J Med 352 (2005) 2576-2578
47. Dixon M.F. Pathophysiology of Helicobacter pylori infection. Scand J Gastroenterol Suppl 201 (1994) 7-10
48. Sobala G.M., King R.F., Axon A.T., et al. Reflux gastritis in the intact stomach. J Clin Pathol 43 (1990) 303-306
49. Quinn C.M., Bjarnason I., and Price A.B. Gastritis in patients on non-steroidal anti-inflammatory drugs. Histopathology 23 (1993) 341-348
50. Stolte M., Panayiotou S., and Schmitz J. Can NSAID/ASA-induced erosions of the gastric mucosa be identified at histology?. Pathol Res Pract 195 (1999) 137-142
51. Levine D.S., Surawicz C.M., Ajer T.N., et al. Diffuse excess mucosal collagen in rectal biopsies facilitates differential diagnosis of solitary rectal ulcer syndrome from other inflammatory bowel diseases. Dig Dis Sci 33 (1988) 1345-1352
52. Oberhuber G., Puspok A., Oesterreicher C., et al. Focally enhanced gastritis. a frequent type of gastritis in patients with Crohn's disease. Gastroenterology 112 (1997) 698-706
53. Wehut W.D., Olmsted W.W., Neiman H.L., et al. Eosinophilic gastritis. Radiologic-pathologic correlation (RPC) from the Armed Forces Institute of Pathology (AFIP). Radiology 120 (1976) 85-89
54. Milman P.J., and Sidhu G.S. Case report. eosinophilic gastritis simulating a neoplasm. Am J Med Sci 276 (1978) 227-230
55. Ikeda K., Kumashiro R., and Kifune T. Nine cases of acute gastric anisakiasis. Gastrointest Endosc 35 (1989) 304-308
56. Whitney A.E., Guarner J., Hutwagner L., et al. Helicobacter pylori gastritis in children and adults. comparative histopathologic study. Ann Diagn Pathol 4 (2000) 279-285
57. Genta R.M., Lew G.M., and Graham D.Y. Changes in the gastric mucosa following eradication of Helicobacter pylori. Mod Pathol 6 (1993) 281-289
58. Price A.B. Pathology of drug-associated gastrointestinal disease. Br J Clin Pharmacol 56 (2003) 477-482
59. Haot J., Jouret A., and Mainguet P. Lymphocytic gastritis. In: Graham D.Y., Genta R.M., and Dixon M.F. (Eds). Gastritis (1999), Lippincott Williams & Wilkins, Philadelphia, PA
60. Capella C., Fiocca R., Cornaggia M., et al. Autoimmune gastritis. In: Graham D.Y., Genta R.M., and Dixon M.F. (Eds). Gastritis (1999), Lippincott Williams & Wilkins, Philadelphia, PA
61. Genta R.M., and Rugge M. Gastric precancerous lesions. heading for an international consensus. Gut 45 suppl 1 (1999) I5-I8
62. Genta R.M. Review article. gastric atrophy and atrophic gastritis-nebulous concepts in search of a definition. Aliment Pharmacol Ther 12 suppl 1 (1998) 17-23
63. Leung W.K., and Sung J.J. Review article. intestinal metaplasia and gastric carcinogenesis. Aliment Pharmacol Ther 16 (2002) 1209-1216
64. Solcia E., Capella C., Vassallo G., et al. Endocrine cells of the gastric mucosa. Int Rev Cytol 42 (1975) 223-286
65. Solcia E., Fiocca R., Villani L., et al. Morphology and pathogenesis of endocrine hyperplasias, precarcinoid lesions, and carcinoids arising in chronic atrophic gastritis. Scand J Gastroenterol Suppl 180 (1991) 146-159
66. Stolte M., Bethke B., Seifert E., et al. Observation of gastric glandular cysts in the corpus mucosa of the stomach under omeprazole treatment. Z Gastroenterol 33 (1995) 146-149
67. Bordi C., D'Adda T., Azzoni C., et al. Neuroendocrine proliferation in the gastric mucosa. biological behaviour and management. Verh Dtsch Ges Pathol 81 (1997) 103-110
68. Fries J.F. NSAID gastropathy: the second most deadly rheumatic disease? Epidemiology and risk appraisal. J Rheumatol Suppl 28 (1991) 6-10